Search Count: 123
 |
Organism: Human alphaherpesvirus 2, Vicugna pacos
Method: X-RAY DIFFRACTION Resolution:3.72 Å Release Date: 2025-05-28 Classification: ANTIVIRAL PROTEIN |
 |
Organism: Human alphaherpesvirus 2, Vicugna pacos
Method: X-RAY DIFFRACTION Resolution:2.88 Å Release Date: 2025-05-28 Classification: ANTIVIRAL PROTEIN Ligands: NAG |
 |
Sars-Cov-2 Papain-Like Protease (Plpro) Complex With Covalent Inhibitor Jun13567
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2025-03-26 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: A1A6J, DTT, ZN, CL |
 |
Organism: Enterovirus d68
Method: ELECTRON MICROSCOPY Release Date: 2025-03-19 Classification: VIRUS Ligands: A1AIC |
 |
Organism: Enterovirus d68
Method: ELECTRON MICROSCOPY Release Date: 2025-03-19 Classification: VIRAL PROTEIN Ligands: A1AIE |
 |
Organism: Enterovirus d68
Method: ELECTRON MICROSCOPY Release Date: 2025-03-19 Classification: VIRAL PROTEIN Ligands: A1AIF |
 |
Organism: Enterovirus d68
Method: ELECTRON MICROSCOPY Release Date: 2025-03-19 Classification: VIRAL PROTEIN Ligands: A1AIG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2025-01-22 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: A1BEG, ACT, ZN, CL, EDO |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2025-01-22 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: A1BEH, ACY, ZN, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2025-01-22 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: A1BF2, PEG, ZN, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2025-01-22 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: A1BEF, PEG, ACT, EDO, ZN, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2025-01-22 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: A1BEE, ACT, ZN, CL, GOL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2025-01-22 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: A1BEL, PEG, ACT, CL, ZN |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) L50F/E166A/L167F Triple Mutant
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.23 Å Release Date: 2024-11-06 Classification: HYDROLASE |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2024-10-09 Classification: HYDROLASE |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-10-09 Classification: HYDROLASE Ligands: GDP, ANP, MG, GNP |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-10-09 Classification: HYDROLASE Ligands: GDP, ANP, MG, GNP |
 |
Amg 193, A Clinical Stage Mta-Cooperative Prmt5 Inhibitor, Drives Anti-Tumor Activity Preclinically And In Patients With Mtap-Deleted Cancers
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.85 Å Release Date: 2024-10-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: GOL, DMS, A1ATH, MTA |
 |
Cryo-Em Structure Of Sars-Cov-2 Omicron Ba.2.86 Spike Protein(6P), 1-Rbd-Up State
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2024-07-03 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Cryo-Em Structure Of Sars-Cov-2 Omicron Eg.5 Spike Protein(6P), Rbd-Closed State
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2024-07-03 Classification: VIRAL PROTEIN Ligands: NAG |